Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Emily Baum: Chilling academic exchanges between China and the U.S. Emily Baum is an associate professor of modern Chinese history and director of the Long U.S.-China Institute, which aims to bridge the gaps between academia, journalism and the public sector. Baum says the pandemic will likely affect study abroad for years to come, in both directions, with negative impacts on both sides. There was already a significant disparity with roughly 370,000 Chinese students studying in the U.S. and only 11,000 Americans studying in China annually. “A drop in Chinese enrollments will have major consequences for the future of higher education in the U.S., where many schools rely on the full tuition paid by international students to stay afloat,” Baum says. But equally worrisome: “The educational decoupling that had already begun before COVID-19 — and will be greatly exacerbated by it — means that there will be far fewer opportunities for each country’s students to gain firsthand knowledge of, and mutual understanding about, the other.” Reach Baum at: emily.baum@uci.edu Wang Feng: China has passed its peak Wang Feng is a professor of sociology and an adjunct professor at Fudan University in Shanghai, China. He is an expert on global social and demographic changes and social inequality. He has served on expert panels for the United Nations and the World Economic Forum, as well as he served as a senior fellow and director at the Brookings Institution Brookings-Tsinghua Center for Public Policy. Wang sees the ascendance of China in the last 40 years as the result of a unique confluence of circumstances: a dynamic leader in Deng Xiaoping, plus a significant rural population that moved to cities and provided a huge labor force. In the last 20 years, China has produced 600 billionaires — and gaping wealth disparities. “When China was poor, people thought it would be poor forever. Now that China is rich, people think it will be rich forever. But China has passed its peak,” he says. “The headwinds of an aging population, the legacy of the one-child policy, and tremendous social inequality will present enormous internal challenges in the years ahead.” Reach Wang at fwang@uci.edu. Jeffrey Wasserstrom: China’s box office changes Hollywood portrayals Jeffrey Wasserstrom is a Chancellor’s professor of history. A specialist in modern Chinese history, he has testified before a Congressional-Executive commission on China, conducted a State Department briefing on contemporary Chinese politics, and worked with the Hong Kong International Literary Festival. His articles have been published by TIME, The Nation, Wall Street Journal, Financial Times, The New York Times and others. Wasserstrom notes that Hollywood films and TV often negatively present whichever East Asian country is most feared at the time. However, the power of China’s box office is changing that. “Due to concern with the massive market for movies in the People’s Republic of China, you do not often see negative portrayals of that country on American screens,” says Wasserstrom. “A telling example of our living in a new era is that when filmmakers were setting out to make a new version of ‘Red Dawn,’ a film that originally portrayed a Russian invasion of the U.S., the plan was to have Chinese soldiers serve as the enemies. Concern about PRC box office receipts led to a change in nationality — the enemies became North Korean soldiers.” Reach Wasserstrom at: jwassers@uci.edu. Yong Chen: Chinese food in the U.S. and China Yong Chen is the author of several books including "Chop Suey, USA: The Story of Chinese Food in America" (Columbia University Press, 2014). He also co-curated “‘Have You Eaten Yet?’: The Chinese Restaurant in America” in Atwater Kent Museum, Philadelphia (2006), and the Museum of Chinese in the Americas, New York City (2004–05). He is professor of history. He points out that the COVID-19 pandemic hastened changes to culinary habits that were already underway in China, including less consumption of wild animals, greater demand for fast food, and a shift away from communal or “family style” meals. Meanwhile, in the U.S., Chinese restaurants have been hit hard by anti-Asian sentiments, while also showing signs of resilience thanks to the popularity of Chinese takeout. “If the seriously strained relationship between China and the US continues to deteriorate, it is possible that more people in America will lose their appetite for Chinese food, to say the least,” Chen says. Reach Chen at: y3chen@uci.edu.
Without Trump – Is Late Night Television Struggling for New Jokes?
For four years, just about every talk show host and comedy show had a fresh supply of almost daily content. The unfiltered comments, gaffes and chaotic ongoings in the White House offered up a steady stream of material for jokes, monologues and coverage. But those days are over. Does Joe Biden's calm presidency and his capable administration mean a deficit of humor for the country’s comedians? UMW’s Dr. Stephen Farnsworth was recently featured in Variety Magazine about his perspective on the current state of late-night political content. Viewers are likely to continue to expect a robust political discussion. “In Washington, the political divisions are as intense as ever, and so it seems that there would be a ready audience for a continuing focus on political humor in late night,” said Stephen Farnsworth, co-author of the 2019 book “Late Night With Trump: Political Humor and the American Presidency” and director of the Center for Leadership and Media Studies at the University of Mary Washington. “The environment may not look all that different post-pandemic.” June 14 - Variety Magazine Dr. Stephen Farnsworth is a sought-after political commentator on presidential politics. He has been widely featured in national media, including The Washington Post, Reuters, The Chicago Tribune and MSNBC. Dr. Farnsworth is available to speak with media any time. Simply click on his icon to arrange an interview today.
New research published in BMJ Open shows that community pharmacy could play a ‘key clinical role’ in the future role of COVID-19 vaccination programmes, according to a study led by Aston University in Birmingham, UK, in collaboration with UK and international researchers. The team found that community pharmacists, as a ‘skilled clinical workforce’, could positively contribute, supporting the community in which they serve - by playing a critical role in ongoing COVID-19 vaccination campaigns. The researchers working on the PERISCOPE study found that community pharmacy is uniquely placed to support individuals, because it is seen by the public as a credible, trustworthy service, which could be key to any future clinical role it might play, especially where addressing vaccine hesitancy in ‘seldom heard’ communities. They are therefore calling on decision-makers to endorse and provide their support for a public health role for community pharmacy. Across the UK, community pharmacy is a critical part of primary care. According to the Kings Fund, as of the end of March 2019, there were more than 11,500 community pharmacies in England alone. It is viewed as one of the four pillars of the primary care system, along with general practice, optical services and dentistry. It has also, in areas of the UK, helped to deliver COVID-19 vaccinations. The study included partners from the Universities of Sheffield, Oxford, Hull and Bradford in the UK, as well as internationally, the University of British Columbia and University of Tasmania. The group reviewed more than a hundred documents including peer reviewed articles, blogs and websites on the role of community pharmacy during COVID-19 and other previous pandemics. Their findings were discussed with more than 30 health professionals and members of the public, to ensure that the findings made sense in the real world. Health professionals included pharmacists, pharmacy technicians, dispensers, counter assistants, and GPs, together with members of the public from a range of diverse ethnic backgrounds. Several recommendations were made by the researchers from the findings of the study. Most significantly the group found it was imperative that policy and practice should focus on the clinical role of community pharmacy. Dr Ian Maidment, reader in clinical pharmacy at Aston University and former community pharmacist leading PERSICOPE, said: “We need to use community pharmacy to a much greater extent for COVID-19 vaccination, particularly for boosters against new variants such as the Delta (Indian) variant. The current model (for example, the large hubs) may not be sustainable in the longer term, particularly if annual COVID-19 vaccination is required. “Our work found some key ways to make this happen. The easy access and local convenience of high street pharmacies makes them an ideal location for vaccinating at-risk populations.” The study includes guidance for policy makers: • Have a clear role for community pharmacy in response to the public health agenda, with that role championed by decision-makers • Involve frontline community pharmacists in the development of policy and service specification in relation to vaccination • Provide prompt, clear, consistent guidelines with adequate detail and enough flexibility to allow community pharmacies to adapt the guidelines to meet the needs of their local population • Provide adequate funding and reimbursement for the delivery and necessary adaptations of any new services community pharmacies are asked to deliver • Provide pharmacy teams with adequate systems to deliver this new role and then trust them to deliver. Hadar Zaman, head of pharmacy and medical sciences at University of Bradford and a community pharmacist, said: “Our research has highlighted the important role community pharmacy has played in overcoming vaccine hesitancy, particularly in ethnic minority communities who have been disproportionately affected by COVID and subsequent mortality. “What comes out very strongly, especially in areas of high social deprivation, is that community pharmacists have worked very closely with their local communities addressing concerns around vaccine safety. “It is through these strongly rooted relationships in local communities that we will ensure vaccine uptake rates in ethnic minority and the wider population can be further improved. Therefore, community pharmacy needs to be seen as an essential delivery partner if the Government is to achieve its national vaccination coverage in the short and long term”. PERISCOPE searched for the best evidence across the world and the team included international collaborators. The findings therefore have international relevance. Maura MacPhee, professor of nursing, University of British Columbia and member of the research team, said: “Our review findings and recommendations for decision-makers, community pharmacists and pharmacy users are adaptable and relevant internationally, including my country, Canada, where community pharmacy has a major role to play in COVID-19 vaccination programmes.” Juanita Breen, also a member of the PERISCOPE team and associate professor of dementia studies at Wicking Dementia Centre, School of Health and Medicine, University of Tasmania, added: "This study demonstrates how pharmacists can contribute towards this important public health initiative and enhance the uptake of the vaccine. “It provides important learnings for other countries on how best to utilise the skills of our most accessible health professional - the community pharmacist." Professor Claire Anderson, chair of the Royal Pharmaceutical Society’s English Board said: “This research clearly demonstrates the vital role community pharmacy has played during the pandemic, providing essential advice to communities and tackling health inequalities in areas of high social deprivation. “Policy makers and commissioners need to take forward the recommendations of this research and ensure the strengths of the community pharmacy network are maximised for the benefits of patients.” Alastair Buxton, director of NHS Services at the Pharmaceutical Services Negotiating Committee, said: “This research provides a timely examination of the role community pharmacy teams have played in supporting their communities to fight back against COVID-19. “By keeping their doors open throughout, pharmacies have maintained day-to-day activities, and managed increased demand for many services - including advice on the management of minor illness. They have also substantially increased the number of flu vaccinations administered and played a key part in the COVID-19 vaccination programme. “These findings will help guide policy in the later stages of the pandemic and guide practice in any future pandemics.” Tony Kelly, a diabetes ambassador, Diabetes Strategic Patient Partner - NHS Birmingham and Solihull Clinical Commissioning Group and member of PERISCOPE, said: "Community pharmacists are ideally placed at the forefront of the vaccination agenda as they are the nucleus of ethnically diverse communities and are often the first point of contact for most people." PERISCOPE was jointly funded by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
America in the 1950’s was all about building highways to pump up the post-war economy and make sure everyone could criss-cross a connected America by car. Urban planners didn’t hesitate to bulldoze neighborhoods that were in the way of this progress. However, history shows that most of those communities that were destroyed housed Black and lower income residents. The result left areas with hot pavement, few green spaces and little tree canopy to provide shade. Recently, UMW’s Pamela Grothe joined the host of With Good Reason to talk about how America needs to undo these past mistakes and make better choices. Grothe recently worked with Jeremy Hoffman, chief scientist at the Science Museum of Virginia, who also appears on the episode, and UMW 2021 graduate Allison Grant on research that explores how redlined communities in Richmond, Virginia, designed to keep Black residents in less desirable neighborhoods, show records of being significantly hotter over the last 30 years than white neighborhoods, which has resulted in more heat-related health issues for Black and lower income residents. Aside from jumping in a pool, trees are our best bet to cool summer heat. Pamela Grothe says we have to be intentional about putting trees in the right places. If you’re a journalist looking to learn more about this topic, then our experts are here to help. Dr. Pamela Grothe is an assistant professor in the Department of Earth and Environmental Sciences as the University of Mary Washington, who earned a Ph.D. in the Paleoclimatology Lab at the Earth and Atmospheric Sciences department at Georgia Institute of Technology. She’s an #expert in climate change and is available to speak with media – simply click on her icon to arrange an interview.
UK inflation rate jumps to 2.1%: University of Warwick experts comment
The Office of National Statistics reports that the inflation rate in the UK has risen to 2.1%, passing the Bank of England target of 2%. Professor Abhinay Muthoo of the University of Warwick Department of Economics and Professor Nigel Driffield of Warwick Business School comment here on what factors could have caused this jump. Professor Abhinay Muthoo of the Department of Economics at the University of Warwick said: "Figures released by the UK’s Office for National Statistics (ONS) show UK inflation has jumped to 2.1% in the year to May. This means inflation is now above the Bank of England target of 2%. There is concern amongst some economists that inflation will rise further, and more importantly, that these higher levels of inflation are permanent. Hence, for example a call by some that the Bank of England should quickly raise interest rates. "I believe this higher than target inflation is very likely to be temporary. This current increase is driven by a few factors. One being a sudden and sharp increase in consumer spending as consumers are rushing to spend their savings from the past year of lockdown, and supply cannot, at the moment, keep up with that strong demand. I expect inflation to return to under Bank of England’s 2% target by around early next year." Professor Nigel Driffield of Warwick Business School said: “Supply of various goods and services is or has been constrained by Covid, and while many people have suffered financially because of Covid there is also a high level of pent up demand. This pertains not only to goods and services made here, but also imported. So for a while we are going to see pressure on inflation as the economy opens up.”
EURO 2020: The Business and Science of Football will see academics from across the University’s three colleges speaking on a variety of topics, including economic recoveries, the sustainability of huge sporting events and the psychology of penalties. It is great to use my research experience to provide a different perspective to a general audience with a project like this. Sporting mega events like Euro 2020 are always topical and it's been really interesting to discover the impact they have on the economy
Juneteenth is this Saturday? Our experts can help with your coverage and questions
June 19 — Juneteenth — marks the day in 1865 that the Union Army announced in Texas that the African American slaves were free. Black Americans since then have honored the day, even as it has gone unnoticed by many others. In 2020, Jessica Millward, an associate professor of history at UCI, appeared on the UCI Podcast to discuss the history behind Juneteenth, the decades upon decades of continued struggle, and the hope she feels in this moment. And if you’re a reporter covering this important date in American history – then let our experts help with your stories. Dr. Jessica Millward is an Associate professor in the Department of History at the University of California, Irvine. Her research focuses on comparative slavery and emancipation, African American history, gender and the law. Dr. Millward is available to speak with media about Juneteenth – simply click on her icon now to arrange an interview today.
Did you know in America more than 6 million people are living with Alzheimer’s disease? June is Alzheimer's and Brain Awareness Month and the experts from Georgia Southern University have been busy talking with reporters and media about the importance of brain health and how to monitor your memory for any signs that may require attention. Earlier this month, Georgia Southern’s Adrienne Cohen spoke to NBC News about Dementia and the many types of brain disorders. Alzheimer’s is one of the many types of Dementia, a brain disorder that causes the brain to create gaps, initially effecting the short-term memory. “It can have several stages,” said Adrienne Cohen, Ph.D, associate professor and director, Center for Social Gerontology . “It can effect your memory, it can effect your mood, it can effect the way you interact with other people. It’s a slow progression, initially people might just be confused or can’t remember things and sadly that happens to all of us.” For many, it can be difficult to determine whether a person’s forgetfulness is caused by a number of underlying factors, like vitamin deficiencies or metabolic-related issues, or if it could potentially be something more serious. June 07 – NBC News With nearly six million Americans effected by Alzheimer’s disease, the chance of being effected doubles every five years for every American as they age after 65. This is an important topic and if you are a reporter looking to cover this subject – then let our experts help. Simply reach out to Georgia Southern Director of Communications Jennifer Wise at jwise@georgiasouthern.edu and she’ll assist with connecting you with Dr. Cohen today.
Expert comment: China and the G7
China has denounced a joint statement by the Group of Seven leaders that had scolded Beijing over a range of issues as a gross interference in the country’s internal affairs, and urged the grouping to stop slandering China. Professor Shaun Breslin, from the Department of Political and International Studies at the University of Warwick comments: "This is simply the latest in what is now a very familiar exercise in pushing back against any perceived criticism of China by the Chinese authorities. And it's really no surprise that China reserves special criticism for what is said by people at a party that it is not invited to. "But there are perhaps a couple of extra dynamics here. One is that questions about the origins of the pandemic aren’t going away; and indeed, seem to be being asked more frequently and more loudly. The second is the possibility of western powers increasingly taking a common position on China in a way that was not very likely when Biden’s predecessor was in power."
UConn Expert on the "FDA's Big Gamble" with Controversial Alzheimer's Drug
The Food and Drug Administration's accelerated approval of the drug aducanumab for the treatment of Alzheimer's disease is mired in controversy -- three scientists have resigned from the independent committee that advised the agency on the monthly infusion treatment priced at $56,000 per year. C. Michael White, distinguished professor and head of the Department of Pharmacy Practice at the University of Connecticut, explains the situation surrounding the drug's approval this week in an essay published by The Conversation: Over 6 million Americans now have Alzheimer’s disease, and deaths from Alzheimer’s have risen over 145% over the past 20 years. Alzheimer’s disease not only robs individuals of their autonomy but also places a huge burden on family members and the U.S. economy: $355 billion is spent annually on caring for people with Alzheimer’s. Current FDA-approved treatments are only modestly effective at controlling disease symptoms, and none target a possible underlying cause. The accelerated approval pathway allows patients with early-stage Alzheimer’s to access aducanumab while a larger and more definitive clinical trial is conducted. Biogen says it hopes to have the clinical trial completed by 2030. If the study does not find reductions in the hard clinical endpoints, the drug will be withdrawn. If aducanumab is ultimately found to be effective, many patients with early-stage Alzheimer’s will reap the benefits in reductions in hospitalizations, doctor visits, nursing home costs and societal burden. If aducanumab is found to be ineffective, however, Medicare, insurers and patients will have spent tens of millions of dollars on a drug that not only did not work but also exposed patients to adverse events, including the risk of bleeding in the brain. June 10 - The Conversation Dr. C. Michael White is an expert in the areas of comparative effectiveness and preventing adverse events from drugs, devices, dietary supplements, and illicit substances. If you are a journalist looking to cover this topic, then let us help. Dr. White is available to speak with media -- click on his icon now to arrange an interview today.
